Spanish scientists create nanoparticles able to attack lethal brain tumor

    Source: Xinhua| 2019-01-16 04:40:58|Editor: yan
    Video PlayerClose

    MADRID, Jan. 15 (Xinhua) -- A group of scientists in the Center of Investigation of Molecular Medicine and Chronic Illness at the University of Santiago de Compostela (CiMUS) have managed to create nanoparticles (particles between 1 and 100 nanometers (nm) in size) that can penetrate a lethal brain tumor to direct drugs into the cancerous cells.

    In a document published by the BBVA Foundation (who helped sponsor the project) on Tuesday, CiMUS explained that the experimental therapy has been successfully tested on human tumors implanted in mice, with the results published in the specialized publication "Advanced Therapeutics".

    The investigative team, led by Dr. Marcos Garcia Fuentes, created nanoparticles able to attack gliobastoma multiforme (GBM) which are the most common and lethal brain tumors, with five-year survival rate of less than 5 percent.

    "The tests with mice have given very good results, with the mice which only received chemotherapy having tumors twice the size of those who received a treatment of chemotherapy and nanoparticles," explained Dr Garcia Fuentes.

    The new treatment does not only reduce the toxicity of current anti-cancer drugs, but also allows them to be transported into the interior of the cancerous cells with greater ease.

    "The secret of this material is that it becomes insoluble in the acid atmosphere of the digestive tract, allowing it to be ejected from the system," added the researcher.

    The use of medication capable to silence the genes which can cause tumors could be vital in developing personalized cancer treatments, but they are still not widely used due to problems with stability and transport within the body.

    CiMUS hope that this new therapy, which has been developed in collaboration with the Carlos III Health Institute and the University of Nottingham (Britain) could be used to treat other tumors, such as melanomas.

    "If everything goes well and we are able to get the support of companies, we will be able to start clinical trials with human patients within 4 or 5 years," explained Dr. Garcia Fuentes.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011105521377466191
    主站蜘蛛池模板: 奇米精品一区二区三区在| 午夜视频十八嗯嗯啊免费| 国产人妖ts丝丝magnet| 午夜亚洲乱码伦小说区69堂| 亚洲综合伊人久久大杳蕉| 亚洲人成网站999久久久综合| 久久精品国产精品亚洲精品| 亚洲国产午夜精品理论片| 亚洲熟妇无码av在线播放| 亚洲精品无码mv在线观看网站| 亚洲偷自精品三十六区| 亚洲免费综合色在线视频| 久久国产乱子伦精品免费强| 九九久久99综合一区二区| 两个人看的www免费高清| 中文字幕影片免费在线观看| 99精品欧美一区二区三区综合在线| 很污很黄的网站| 777奇米影视视频在线播放| 色爱无码av综合区| 欧美黑人性暴力猛交喷水| 欧美电影《轻佻寡妇》| 欧美国产日韩a在线视频| 欧美成a人片在线观看久| 无码色偷偷亚洲国内自拍| 成人欧美一区二区三区的电影| 成人私人影院在线版| 国产精品高清一区二区三区| 国产精品酒店视频| 国产精品一区二区av| 和前辈夫妇交换性3中文字幕| 免费看片A级毛片免费看| 亚洲韩国欧美一区二区三区| 久久综合香蕉国产蜜臀av| eeuss影院在线观看| 91久久精品国产91久久性色也 | 久久精品国产99久久久古代 | 亚洲毛片在线免费观看| 中文字幕无码日韩欧毛| 五月婷在线视频| 污污内射在线观看一区二区少妇|